Skip to main content

Table 1 Patient and primary tumor characteristics

From: Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective study

 

Group A n = 107

Group B n = 98

p-value

Age medium (range years)

66 (32–89)

65 (25–86)

0.601

Sex (n%)

0.869

 Male

84 (78.5)

76 (77.6)

 

 Female

23 (21.5)

22 (22.4)

 

T category (n%)

0.393

 Ta

26 (24.3)

29 (29.6)

 

 T1

81 (75.7)

69 (70.4)

 

Grade (n%)

0.402

 Low grade

44 (41.1)

46 (46.9)

 

 High grade

63 (58.9)

52 (53.1)

 

CIS (n%)

0.248

 No

104 (97.2)

98 (100)

 

 YES

3 (2.8)

0 (0)

 

Tumor size (n%)a

0.358

  < 3 cm

77 (72.0)

76 (77.6)

 

  ≥ 3 cm

30 (28.0)

22 (22.4)

 

Multifocal (n%)

0.527

 No

38 (35.5)

39 (39.8)

 

 YES

69 (64.5)

59 (60.2)

 
  1. aMaximum size of largest tumor resected